Smarter scans for breast cancer survivors: could personalized imaging catch recurrences earlier?

NCT ID NCT07426510

Not yet recruiting Diagnosis Sponsor: Umeå University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether using more sensitive imaging (like MRI or contrast mammograms) based on a woman's personal risk can detect breast cancer recurrences earlier than standard mammograms. It will involve 2,300 women who had breast-conserving surgery and are at higher risk of recurrence. The goal is to see if personalized surveillance reduces the number of cancers found between scheduled screenings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Risk-stratified imaging surveillance (MRI or contrast-enhanced mammography)
What this could lead to: If successful, this could lead to earlier detection of breast cancer recurrences, potentially improving survival and reducing the need for more aggressive treatments.
What could go wrong: This is a large but early-stage trial that hasn't started recruiting yet. The more sensitive imaging may also increase false alarms and unnecessary biopsies, and it's not yet proven to improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

More trials for these conditions

Other studies related to the condition(s) this trial covers.